Drug intelligence / Profile preview

ethylenediamine

Development stage
Unknown
Modality
Small Molecules
Administration
Topical, Intravenous
01

Overview

Ethylenediamine is a small organic compound (C2H8N2) primarily used as an industrial chemical building block and excipient in pharmaceutical preparations such as creams. It is a colorless liquid with an ammonia-like odor and serves as a stabilizer for certain drugs, notably aminophylline, by increasing their solubility. In medicine, its main approved use is within allergenic epicutaneous patch tests to aid in the diagnosis of allergic contact dermatitis. Ethylenediamine acts as a contact sensitizer and can cause local or generalized allergic reactions upon exposure[1][2][3][4]. Mechanistically, it has been shown to activate Gamma-aminobutyric acid (GABA) receptors in the central and peripheral nervous systems—partly by direct action and partly by releasing endogenous GABA—though this effect is not its primary clinical application[6]. Industrially, it is also used in the synthesis of chelating agents (such as EDTA), epoxy curing agents, resins, emulsifiers, textile lubricants, antifreeze inhibitors, and other chemicals[4][5].

Other names
1,2-diaminoethanediaminoethane
02

Targets

DHPS (Dihydropteroate synthase)GABA-B (Gamma-aminobutyric acid receptor type B)

Beyond the preview

Go deeper on ethylenediamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethylenediamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call